Agbio a fast-growing sector in N.C.'s life science industry
Related Blog Posts
- Opinion: Pharma follows as the CROs fly
- New Jersey firm buying Gentris for $4.75M; founder to return
- Holly Springs' Novartis plant symbolizes healthcare revolution
- Even without a script, Bob Ingram can spin a crowd
- BioCryst drug scores well in trial, launches $100M stock offering
- Ag biotech startups flex muscles at NCBiotech showcase
- Ag Biotech Showcase to highlight nine emerging NC, regional firms
- Durham-based Novan wins 'Buzz of Bio' spotlight
- NC Biotech Center awards $2.5M in grants, funding
On The Web
Editor's Note: As the North Carolina Biotechnology Center and a host of biotech and life science companies within the state head to San Diego, Calif., for the national BIO convention, Robin Deacle, vice president of corporate communications for the center, provides an overview of a key sector of the North Carolina’s life science industry: Agbio. On Monday, Jim Shamp of the Center reviewed the state's contract research organization sector.
RESEARCH TRIANGLE PARK, N.C. - The United Nations projects that by 2050, we’ll have nine billion people in the world. Those additional 1.8 billion people will need to eat. Where will all that food come from?
It’s a question that North Carolina companies are researching in earnest.
For example, we know we’ll need crops that tolerate drought, but will there be new ways of controlling pests and disease? North Carolina has companies working on that.
We’ll need new sources of protein, including new feed grains for our meat animal industry. North Carolina has people working on that.
Will plants need to get new life as green medicine factories? North Carolina even has companies working on that.
More than 80 ag biotech companies and a workforce of 8,000 call North Carolina home. Five of the top six ag biotech companies have headquarters or major research facilities in the state. And numerous entrepreneurial companies are developing the technologies that will help us meet future demand for food.
Ag biotech isn’t limited to food, though that’s a pretty important topic. North Carolina’s companies are developing biofuels, vaccines, antibiotics, diagnostics and early-warning tests for biodefense.
The North Carolina Biotechnology Center’s Ag Biotech Initiative is working to grow this sector for the state. Launched in 2009, the initiative has connected large companies, entrepreneurial companies and supporting partners statewide to catalyze ag biotech cluster development. Some of the state’s recent successes:
BASF, Bayer CropScience, Novozymes and Syngenta, all with headquarters in North Carolina, announced major expansions in the state.
The Biotechnology Crop Commercialization Center’s first project to replace feed corn for the meat animal industry increased sorghum production five-fold and created significant cost savings.
The nation’s first ag biotech high school is preparing to welcome its third class this fall.
NCBiotech’s ag biotech initiative is one of the nearly 30 participants in the North Carolina Pavilion at the BIO International Convention June 23-26 in San Diego.
(C) N.C. Biotechnology Center
Please Log In to add a comment.
Best of TechWire Insider
- Microsoft paints sunny earnings picture
- Crowdfunding bill moves - again - as part of different legislation
- AT&T already seeking permits for rollout of ultrafast network
- Latest stats show institutional venture capital in N.C. becoming a joke
- With cities on board, N.C. Next Generation Network is rolling toward first big deployment target
- Is IBM-Apple deal a slap in the face for Lenovo?
- A rare look into economic recruitment, requirements: Cary's disappearing 1,237 jobs document
- N.C. Senate committee to consider crowdfunding bill
- NCTA renames its '21 Awards,' to honor winners with 'Beacon'
- Vivek Wadhwa's book 'Innovating Women' hits markets Sept. 2